ALC•benzinga•
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
Summary
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 29, 2025 by benzinga